Global and China Plasma Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Oct-2021
No. of pages: 108
Inquire Before Buying

Global Plasma Therapeutics Scope and Market Size

Plasma Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Human Serum Protein

- Plasma-Derived Clotting Factor

- Immunoglobulins

- High Immunoglobulins

Segment by Application

- Research Laboratories And Institutions

- Hospitals

- Stand-Alone Blood Banks

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Baxter

- CSL Behring

- Grifols Therapeutics

- Octapharma

- Abeona Therapeutics

- ADMA Biologics

- Amag Pharmaceuticals

- Antares Pharma

- BioDelivery Sciences

- Bio Products Laboratory

- Biota Pharmaceuticals

- Biotest Pharmaceuticals

- China Biologic Products

Global and China Plasma Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Human Serum Protein
1.2.3 Plasma-Derived Clotting Factor
1.2.4 Immunoglobulins
1.2.5 High Immunoglobulins
1.3 Market by Application
1.3.1 Global Plasma Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research Laboratories And Institutions
1.3.3 Hospitals
1.3.4 Stand-Alone Blood Banks
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma Therapeutics Market Perspective (2016-2027)
2.2 Plasma Therapeutics Growth Trends by Regions
2.2.1 Plasma Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Plasma Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Plasma Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Plasma Therapeutics Industry Dynamic
2.3.1 Plasma Therapeutics Market Trends
2.3.2 Plasma Therapeutics Market Drivers
2.3.3 Plasma Therapeutics Market Challenges
2.3.4 Plasma Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Therapeutics Players by Revenue
3.1.1 Global Top Plasma Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Plasma Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Plasma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Plasma Therapeutics Revenue
3.4 Global Plasma Therapeutics Market Concentration Ratio
3.4.1 Global Plasma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Therapeutics Revenue in 2020
3.5 Plasma Therapeutics Key Players Head office and Area Served
3.6 Key Players Plasma Therapeutics Product Solution and Service
3.7 Date of Enter into Plasma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Therapeutics Breakdown Data by Type
4.1 Global Plasma Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Plasma Therapeutics Forecasted Market Size by Type (2022-2027)
5 Plasma Therapeutics Breakdown Data by Application
5.1 Global Plasma Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Plasma Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Plasma Therapeutics Market Size (2016-2027)
6.2 North America Plasma Therapeutics Market Size by Type
6.2.1 North America Plasma Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Plasma Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Plasma Therapeutics Market Size by Type (2016-2027)
6.3 North America Plasma Therapeutics Market Size by Application
6.3.1 North America Plasma Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Plasma Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Plasma Therapeutics Market Size by Application (2016-2027)
6.4 North America Plasma Therapeutics Market Size by Country
6.4.1 North America Plasma Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Plasma Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasma Therapeutics Market Size (2016-2027)
7.2 Europe Plasma Therapeutics Market Size by Type
7.2.1 Europe Plasma Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Plasma Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Plasma Therapeutics Market Size by Type (2016-2027)
7.3 Europe Plasma Therapeutics Market Size by Application
7.3.1 Europe Plasma Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Plasma Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Plasma Therapeutics Market Size by Application (2016-2027)
7.4 Europe Plasma Therapeutics Market Size by Country
7.4.1 Europe Plasma Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Plasma Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Plasma Therapeutics Market Size by Type
8.2.1 Asia-Pacific Plasma Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Plasma Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Plasma Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Plasma Therapeutics Market Size by Application
8.3.1 Asia-Pacific Plasma Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Plasma Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Plasma Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Plasma Therapeutics Market Size by Region
8.4.1 Asia-Pacific Plasma Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Plasma Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasma Therapeutics Market Size (2016-2027)
9.2 Latin America Plasma Therapeutics Market Size by Type
9.2.1 Latin America Plasma Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Plasma Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Plasma Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Plasma Therapeutics Market Size by Application
9.3.1 Latin America Plasma Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Plasma Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Plasma Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Plasma Therapeutics Market Size by Country
9.4.1 Latin America Plasma Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Plasma Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Plasma Therapeutics Market Size by Type
10.2.1 Middle East & Africa Plasma Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Plasma Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Plasma Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Plasma Therapeutics Market Size by Application
10.3.1 Middle East & Africa Plasma Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Plasma Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Plasma Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Plasma Therapeutics Market Size by Country
10.4.1 Middle East & Africa Plasma Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Plasma Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Plasma Therapeutics Introduction
11.1.4 Baxter Revenue in Plasma Therapeutics Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 CSL Behring
11.2.1 CSL Behring Company Details
11.2.2 CSL Behring Business Overview
11.2.3 CSL Behring Plasma Therapeutics Introduction
11.2.4 CSL Behring Revenue in Plasma Therapeutics Business (2016-2021)
11.2.5 CSL Behring Recent Development
11.3 Grifols Therapeutics
11.3.1 Grifols Therapeutics Company Details
11.3.2 Grifols Therapeutics Business Overview
11.3.3 Grifols Therapeutics Plasma Therapeutics Introduction
11.3.4 Grifols Therapeutics Revenue in Plasma Therapeutics Business (2016-2021)
11.3.5 Grifols Therapeutics Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Plasma Therapeutics Introduction
11.4.4 Octapharma Revenue in Plasma Therapeutics Business (2016-2021)
11.4.5 Octapharma Recent Development
11.5 Abeona Therapeutics
11.5.1 Abeona Therapeutics Company Details
11.5.2 Abeona Therapeutics Business Overview
11.5.3 Abeona Therapeutics Plasma Therapeutics Introduction
11.5.4 Abeona Therapeutics Revenue in Plasma Therapeutics Business (2016-2021)
11.5.5 Abeona Therapeutics Recent Development
11.6 ADMA Biologics
11.6.1 ADMA Biologics Company Details
11.6.2 ADMA Biologics Business Overview
11.6.3 ADMA Biologics Plasma Therapeutics Introduction
11.6.4 ADMA Biologics Revenue in Plasma Therapeutics Business (2016-2021)
11.6.5 ADMA Biologics Recent Development
11.7 Amag Pharmaceuticals
11.7.1 Amag Pharmaceuticals Company Details
11.7.2 Amag Pharmaceuticals Business Overview
11.7.3 Amag Pharmaceuticals Plasma Therapeutics Introduction
11.7.4 Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021)
11.7.5 Amag Pharmaceuticals Recent Development
11.8 Antares Pharma
11.8.1 Antares Pharma Company Details
11.8.2 Antares Pharma Business Overview
11.8.3 Antares Pharma Plasma Therapeutics Introduction
11.8.4 Antares Pharma Revenue in Plasma Therapeutics Business (2016-2021)
11.8.5 Antares Pharma Recent Development
11.9 BioDelivery Sciences
11.9.1 BioDelivery Sciences Company Details
11.9.2 BioDelivery Sciences Business Overview
11.9.3 BioDelivery Sciences Plasma Therapeutics Introduction
11.9.4 BioDelivery Sciences Revenue in Plasma Therapeutics Business (2016-2021)
11.9.5 BioDelivery Sciences Recent Development
11.10 Bio Products Laboratory
11.10.1 Bio Products Laboratory Company Details
11.10.2 Bio Products Laboratory Business Overview
11.10.3 Bio Products Laboratory Plasma Therapeutics Introduction
11.10.4 Bio Products Laboratory Revenue in Plasma Therapeutics Business (2016-2021)
11.10.5 Bio Products Laboratory Recent Development
11.11 Biota Pharmaceuticals
11.11.1 Biota Pharmaceuticals Company Details
11.11.2 Biota Pharmaceuticals Business Overview
11.11.3 Biota Pharmaceuticals Plasma Therapeutics Introduction
11.11.4 Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021)
11.11.5 Biota Pharmaceuticals Recent Development
11.12 Biotest Pharmaceuticals
11.12.1 Biotest Pharmaceuticals Company Details
11.12.2 Biotest Pharmaceuticals Business Overview
11.12.3 Biotest Pharmaceuticals Plasma Therapeutics Introduction
11.12.4 Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021)
11.12.5 Biotest Pharmaceuticals Recent Development
11.13 China Biologic Products
11.13.1 China Biologic Products Company Details
11.13.2 China Biologic Products Business Overview
11.13.3 China Biologic Products Plasma Therapeutics Introduction
11.13.4 China Biologic Products Revenue in Plasma Therapeutics Business (2016-2021)
11.13.5 China Biologic Products Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Plasma Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Human Serum Protein
Table 3. Key Players of Plasma-Derived Clotting Factor
Table 4. Key Players of Immunoglobulins
Table 5. Key Players of High Immunoglobulins
Table 6. Global Plasma Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Plasma Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Plasma Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Plasma Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Plasma Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Plasma Therapeutics Market Share by Regions (2022-2027)
Table 12. Plasma Therapeutics Market Trends
Table 13. Plasma Therapeutics Market Drivers
Table 14. Plasma Therapeutics Market Challenges
Table 15. Plasma Therapeutics Market Restraints
Table 16. Global Plasma Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Plasma Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Plasma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Therapeutics as of 2020)
Table 19. Ranking of Global Top Plasma Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Plasma Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Plasma Therapeutics Product Solution and Service
Table 23. Date of Enter into Plasma Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Plasma Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Plasma Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Plasma Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Plasma Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Plasma Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Plasma Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Plasma Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Plasma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Plasma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Plasma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Plasma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Plasma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Plasma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Plasma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Plasma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Plasma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Plasma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Plasma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Plasma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Plasma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Plasma Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Plasma Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Plasma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Plasma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Plasma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Plasma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Plasma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Plasma Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Plasma Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Plasma Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Plasma Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Plasma Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Plasma Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Baxter Company Details
Table 64. Baxter Business Overview
Table 65. Baxter Plasma Therapeutics Product
Table 66. Baxter Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Baxter Recent Development
Table 68. CSL Behring Company Details
Table 69. CSL Behring Business Overview
Table 70. CSL Behring Plasma Therapeutics Product
Table 71. CSL Behring Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 72. CSL Behring Recent Development
Table 73. Grifols Therapeutics Company Details
Table 74. Grifols Therapeutics Business Overview
Table 75. Grifols Therapeutics Plasma Therapeutics Product
Table 76. Grifols Therapeutics Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Grifols Therapeutics Recent Development
Table 78. Octapharma Company Details
Table 79. Octapharma Business Overview
Table 80. Octapharma Plasma Therapeutics Product
Table 81. Octapharma Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Octapharma Recent Development
Table 83. Abeona Therapeutics Company Details
Table 84. Abeona Therapeutics Business Overview
Table 85. Abeona Therapeutics Plasma Therapeutics Product
Table 86. Abeona Therapeutics Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Abeona Therapeutics Recent Development
Table 88. ADMA Biologics Company Details
Table 89. ADMA Biologics Business Overview
Table 90. ADMA Biologics Plasma Therapeutics Product
Table 91. ADMA Biologics Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 92. ADMA Biologics Recent Development
Table 93. Amag Pharmaceuticals Company Details
Table 94. Amag Pharmaceuticals Business Overview
Table 95. Amag Pharmaceuticals Plasma Therapeutics Product
Table 96. Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Amag Pharmaceuticals Recent Development
Table 98. Antares Pharma Company Details
Table 99. Antares Pharma Business Overview
Table 100. Antares Pharma Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Antares Pharma Recent Development
Table 102. BioDelivery Sciences Company Details
Table 103. BioDelivery Sciences Business Overview
Table 104. BioDelivery Sciences Plasma Therapeutics Product
Table 105. BioDelivery Sciences Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 106. BioDelivery Sciences Recent Development
Table 107. Bio Products Laboratory Company Details
Table 108. Bio Products Laboratory Business Overview
Table 109. Bio Products Laboratory Plasma Therapeutics Product
Table 110. Bio Products Laboratory Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Bio Products Laboratory Recent Development
Table 112. Biota Pharmaceuticals Company Details
Table 113. Biota Pharmaceuticals Business Overview
Table 114. Biota Pharmaceuticals Plasma Therapeutics Product
Table 115. Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 116. Biota Pharmaceuticals Recent Development
Table 117. Biotest Pharmaceuticals Company Details
Table 118. Biotest Pharmaceuticals Business Overview
Table 119. Biotest Pharmaceuticals Plasma Therapeutics Product
Table 120. Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 121. Biotest Pharmaceuticals Recent Development
Table 122. China Biologic Products Company Details
Table 123. China Biologic Products Business Overview
Table 124. China Biologic Products Plasma Therapeutics Product
Table 125. China Biologic Products Revenue in Plasma Therapeutics Business (2016-2021) & (US$ Million)
Table 126. China Biologic Products Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Human Serum Protein Features
Figure 3. Plasma-Derived Clotting Factor Features
Figure 4. Immunoglobulins Features
Figure 5. High Immunoglobulins Features
Figure 6. Global Plasma Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Research Laboratories And Institutions Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Stand-Alone Blood Banks Case Studies
Figure 10. Plasma Therapeutics Report Years Considered
Figure 11. Global Plasma Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Plasma Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Plasma Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Plasma Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Plasma Therapeutics Market Share by Players in 2020
Figure 16. Global Top Plasma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Plasma Therapeutics Revenue in 2020
Figure 18. Global Plasma Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Plasma Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Plasma Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Plasma Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Plasma Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Plasma Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Plasma Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Plasma Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Plasma Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Plasma Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Plasma Therapeutics Market Share by Region (2016-2027)
Figure 40. China Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Plasma Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Plasma Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Plasma Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Plasma Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Plasma Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Plasma Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Plasma Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Baxter Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 60. CSL Behring Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 61. Grifols Therapeutics Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 62. Octapharma Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 63. Abeona Therapeutics Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 64. ADMA Biologics Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 65. Amag Pharmaceuticals Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 66. Antares Pharma Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 67. BioDelivery Sciences Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 68. Bio Products Laboratory Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 69. Biota Pharmaceuticals Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 70. Biotest Pharmaceuticals Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 71. China Biologic Products Revenue Growth Rate in Plasma Therapeutics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs